Polyamines in human breast cancer and its relations to classical prognostic features: Clinical implications

Anticancer Research

Volumn 19, Issue 3 B, 1999, Pages 2275-2279

  Leveque, Jean ^b   Bansard, Jean Yves ^a   Watier, Eric ^c   Catros Quemener, Veronique ^a   Havouis, Rene ^a   Moulinoux, Jacques Philippe ^a   Grall, Jean Yves ^c   Seiler, Nikolaus ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b Clinique Gynécologique B   (France)

^c NONE

Author keywords

Axillary nodes; Breast cancer; Histological grade; Hormone receptors; Ki 67 index; Mitosis; Polyamines; Prognosis

Indexed keywords

ESTROGEN; KI 67 ANTIGEN; POLYAMINE; PROGESTERONE;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ERYTHROCYTE; FEMALE; FIBROADENOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MITOSIS RATE; POLYAMINE METABOLISM; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; ERYTHROCYTES; FEMALE; HUMANS; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PUTRESCINE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REFERENCE VALUES; SPERMIDINE; SPERMINE;

EID: 0032790610     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Pegg AE, Mc Cann PP: Polyamine metabolism and function: a brief review. Am J Physiol 243: 212-221, 1982.
2. Jänne J, Pös H, Raina A: Polyamines in rapid growth and cancer. Biochim Biophys Acta 473: 241-293, 1978.
3. Scalabrino G, Ferioli ME: Polyamines in mammalian tumors. Adv Cancer Res 36: 1-102, 1982.
4. Lessard M, Zao C, Singh S, Poulin R: Hormonal and feedback regulation of putrescine and spermidine transport in human breast cancer cells. J Biol Chem 270: 1685-94, 1995.
5. Thomas T, Thomas T: Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications. Breast Cancer Res Tr 29: 189-201, 1993.
6. Glikman P, Manni A, Demers L, Bartholomew M: Polyamine involvement in the growth of hormone-responsive and -resistant human breast cancer cells in culture. Cancer Res 49: 1371-1376, 1989.
7. Thomas T, Kiang D, Jänne O, Thomas T: Variations in amplification and expression of the ornithine decarboxylase gene in human breast cancer cells. Breast Cancer Res Tr 19: 257-267, 1991.
8. Manni A, Badger B, Martel J, Demers L: Role of polyamines on the growth of hormone-responsive and -resistant in human breast cancer cellsin nude mice. Cancer Lett 66: 1-9, 1992.
9. Kremmer T, Palyi I, Daubner D, Boldizsar M, Vincze B, Paulik E, Sugar J, Pokorny E, Tury E: Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts. Anticancer Res 11: 1807-1814, 1991.
10. Manni A, Badger B, Lynch J, Glikman P, Demers L: Hormonal control of polyamine pools in experimental breast cancer in vivo: correlation with estrogen and progesterone receptor levels. Breast Cancer Res Tr 14: 227-234, 1989.
11. Romano M, Cecco L, Cerra M: Levels of polyamines and nucleic acids in human breast carcinoma. Tumori 67: 431-435, 1981.
12. Romano M, Santacroce M, Bonelli P, Cecco L, Cerra M: Differences in polyamine metabolism between carcinomatous and uninvolved human breast tissues. Int J Biol Markers 2: 77-80, 1986.
13. Kingnorth AN, Wallace HM , Bundred NJ, Dixon JMJ: Polyamines in breast cancer. Br J Surg 71: 352-356, 1984.
14. Manni A, Mauger D, Gimotty P, Badger B: Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer. Clin Can Res 2: 1901-1906, 1996.
15. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as target for chemotherapy. Cancer Res 48: 759-774, 1988.
16. Sarhan S, Knodgen B, Seiler N: The gastrointestinal tract as a polyamine source for tumor growth. Anticancer Res 9: 215-224, 1987.
17. Quemener V, Moulinoux JP, Havouis R, Seiler N: Polyamine deprivation enhances antitumoral efficacy of chemotherapy. Anticancer Res 12: 1447-1454, 1992.
18. Azzopardi JG: Histological typing of breast tumours. WHO 1968 International Histological Classification of tumours. Geneve 1981. Ann Pathol 2: 91-105, 1982.
19. Union Internationale Contre le Cancer (UICC). Tumeurs du sein. TNM classification des tumeurs malignes. Paris : Springer Verlag, 1988: 99-106.
20. Bloom J, Richardson WW: Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 357-377, 1957.
21. Le Doussal V, Tubiana-Houlin M, Friedman S, Hacene K, Spyratos F, Brunet M: Prognostic value of histological grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64: 1914-1921, 1989.
22. Cipolla B, Moulinoux JP, Quemener V, Havouis R, Martin L, Guillé F, Lobel B: Erythrocyte polyamine levels in human prostatic carcinoma. J Urol 144: 1164-1166, 1990.
23. Becciolini A, Porciani S, Balzi M, Lanini A, Scubla E, Pacini P, Benucci A, Distante V: Cell kinetics and biochemical parameters in breast cancer. Int J Biol Markers 7: 16-20, 1992.
24. Manni A, Grove R, Kunzelman S, Aldaz M: Involvement of the polyamine pathway in breast cancer progression. Cancer Lett 92: 49-57, 1995.
25. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell-proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Imuunol 133: 1710-1715, 1984.
26. Moulinoux JP, Quemener V, Le Calvo ML, Chatel M, Darcel F: Polyamines in human brain tumors: A correlative study between tumor, cerebrospinal fluid and red blood cell free polyamine levels. J Neuro-oncol 2: 153-158, 1984.
27. Quemener V, Le Gall E, Edan C, Moulinoux JP: Red blood cell polyamine levels in children with acute leukemia: their clinical interest in disease staging and monitoring of therapy efficiency. Cancer J 4: 174-179, 1986.
28. Imandar NA, Redkar SL, Damle M, Damle SR. Clinical significance of serum spermine in breast cancer. Tumori 74: 171-176, 1988.
29. Saydjar R, Alexander RW, Upp JR, Barranco SC, Townsend CM, Thompson JC: Differential sensitivity of various human tumors to inhibition of polyamine biosynthesis in vivo. Int J Cancer 47: 44-48, 1991.